University and SomaLogic announce agreement for discovery
- 8 February 2016
The University of Oxford has signed a collaborative agreement with biotechnology firm SomaLogic.
The agreement will see the partners undertake a number of collaborative projects that will employ SomaLogic's proprietary SOMAmer® reagents and SOMAscan® assay technologies to discover and characterize protein biomarkers for a range of clinical diseases and conditions.
In order to maximize the collaborative nature of these projects and accelerate the translation of discoveries into clinical testing, the agreement also includes the build-out of a SOMAscan assay service laboratory at Oxford under the direction of SomaLogic personnel.